Webinar - Oncology Treatment Updates - 1 Feb 2022
Welcome & Introduction
Consistently Superior Overall Survival with Kryxana
Optimal Management of EGFRm NSCLC Patients
Newer Paradigms in the Treatment of Resected EGFRm Early Lung Cancer
Panel Discussion - Managing Early Stage Lung Cancer Patients
Closing Remarks